These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Production of lentiviral vectors for transducing cells from the central nervous system. Li M; Husic N; Lin Y; Snider BJ J Vis Exp; 2012 May; (63):e4031. PubMed ID: 22664962 [TBL] [Abstract][Full Text] [Related]
3. Production of Lentivirus for the Establishment of CAR-T Cells. Lana MG; Strauss BE Methods Mol Biol; 2020; 2086():61-67. PubMed ID: 31707667 [TBL] [Abstract][Full Text] [Related]
7. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector. Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055 [TBL] [Abstract][Full Text] [Related]
9. Quantitative polymerase chain reaction as a reliable method to determine functional lentiviral titer after ex vivo gene transfer in human mesenchymal stem cells. Böcker W; Rossmann O; Docheva D; Malterer G; Mutschler W; Schieker M J Gene Med; 2007 Jul; 9(7):585-95. PubMed ID: 17510916 [TBL] [Abstract][Full Text] [Related]
10. Simplified production and concentration of lentiviral vectors to achieve high transduction in primary human T cells. Cribbs AP; Kennedy A; Gregory B; Brennan FM BMC Biotechnol; 2013 Nov; 13():98. PubMed ID: 24215295 [TBL] [Abstract][Full Text] [Related]
11. Optimized Production of Lentiviral Vectors for CAR-T Cell. Moço PD; de Abreu Neto MS; Fantacini DMC; Picanço-Castro V Methods Mol Biol; 2020; 2086():69-76. PubMed ID: 31707668 [TBL] [Abstract][Full Text] [Related]
12. An optimized method for high-titer lentivirus preparations without ultracentrifugation. Jiang W; Hua R; Wei M; Li C; Qiu Z; Yang X; Zhang C Sci Rep; 2015 Sep; 5():13875. PubMed ID: 26348152 [TBL] [Abstract][Full Text] [Related]
13. Packaging HIV- or FIV-based lentivector expression constructs and transduction of VSV-G pseudotyped viral particles. Mendenhall A; Lesnik J; Mukherjee C; Antes T; Sengupta R J Vis Exp; 2012 Apr; (62):e3171. PubMed ID: 22508377 [TBL] [Abstract][Full Text] [Related]
14. HIV-1-based lentiviral vectors. Liu YP; Berkhout B Methods Mol Biol; 2014; 1087():273-84. PubMed ID: 24158830 [TBL] [Abstract][Full Text] [Related]
15. Improved third-generation lentiviral packaging with pLKO.1C vectors. Lee S; Cobrinik D Biotechniques; 2020 Jun; 68(6):349-352. PubMed ID: 32141762 [TBL] [Abstract][Full Text] [Related]
16. Production of High-Titer Lentiviral Particles for Stable Genetic Modification of Mammalian Cells. Larcombe MR; Manent J; Chen J; Mishra K; Liu X; Nefzger CM Methods Mol Biol; 2019; 1940():47-61. PubMed ID: 30788817 [TBL] [Abstract][Full Text] [Related]
17. Optimized protocol for high-titer lentivirus production and transduction of primary fibroblasts. He X; He Q; Yu W; Huang J; Yang M; Chen W; Han W J Basic Microbiol; 2021 May; 61(5):430-442. PubMed ID: 33683727 [TBL] [Abstract][Full Text] [Related]
18. Production and Concentration of Lentivirus for Transduction of Primary Human T Cells. Kennedy A; Cribbs AP Methods Mol Biol; 2016; 1448():85-93. PubMed ID: 27317175 [TBL] [Abstract][Full Text] [Related]
19. Factors influencing the titer and infectivity of lentiviral vectors. Logan AC; Nightingale SJ; Haas DL; Cho GJ; Pepper KA; Kohn DB Hum Gene Ther; 2004 Oct; 15(10):976-88. PubMed ID: 15585113 [TBL] [Abstract][Full Text] [Related]
20. Real-time quantitative reverse transcriptase-polymerase chain reaction as a method for determining lentiviral vector titers and measuring transgene expression. Lizée G; Aerts JL; Gonzales MI; Chinnasamy N; Morgan RA; Topalian SL Hum Gene Ther; 2003 Apr; 14(6):497-507. PubMed ID: 12718761 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]